PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease
Acta Neuropathologica · 2024
DOI: 10.1007/s00401-024-02787-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Sophie Schröder und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. Hauptthemen laut MEDLINE: Astrocytes, Alzheimer Disease, RNA, Long Noncoding, DNA-Binding Proteins. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, NIA NIH HHS, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft.
Themen: Demenz
Abstract (Originalsprache)
Astrocytes provide crucial support for neurons, contributing to synaptogenesis, synaptic maintenance, and neurotransmitter recycling. Under pathological conditions, deregulation of astrocytes contributes to neurodegenerative diseases such as Alzheimer’s disease (AD). While most research in this field has focused on protein-coding genes, non-coding RNAs, particularly long non-coding RNAs (lncRNAs), have emerged as significant regulatory molecules. In this study, we identified the lncRNA PRDM16-DT as highly enriched in the human brain, where it is almost exclusively expressed in astrocytes. PRDM16-DT and its murine homolog, Prdm16os , are downregulated in the brains of AD patients and in AD models. In line with this, knockdown of PRDM16-DT and Prdm16os revealed its critical role in maintaining astrocyte homeostasis and supporting neuronal function by regulating genes essential for glutamate uptake, lactate release, and neuronal spine density through interactions with the RE1-Silencing Transcription factor (Rest) and Polycomb Repressive Complex 2 (PRC2). Notably, CRISPR-mediated overexpression of Prdm16os mitigated functional deficits in astrocytes induced by stimuli linked to AD pathogenesis. These findings underscore the importance of PRDM16-DT in astrocyte function and its potential as a novel therapeutic target for neurodegenerative disorders characterized by astrocyte dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
- Bioinformatics Unit, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
- NGS- Integrative Genomics Core Unit, Institute of Pathology, University Medical Center, Göttingen, Germany.
- Research Group for Genome Dynamics in Brain Diseases, German Center for Neurodegenerative Diseases, Göttingen, Germany.
- Department of Pathology and Laboratory Medicine, Boston University School of Medicine, 670 Albany Street, Boston, MA, 02118, USA.
- Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. afische2@gwdg.de.
ORCID-Profile: Andre Fischer
Förderung
- Deutsche Forschungsgemeinschaft
- NIA NIH HHS
- Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
Zitieren
APA
Schröder, S., Fuchs, U., Gisa, V., Pena, T., Krüger, D. M., Hempel, N., Burkhardt, S., Salinas, G., Schütz, A. L., Delalle, I., Sananbenesi, F., & Fischer, A. (2024). PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02787-x
Vancouver
Schröder S, Fuchs U, Gisa V, Pena T, Krüger DM, Hempel N, et al. PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02787-x
BibTeX
@article{Schrder2024,
author = {Schröder, Sophie and Fuchs, Ulrike and Gisa, Verena and Pena, Tonatiuh and Krüger, Dennis M and Hempel, Nina and Burkhardt, Susanne and Salinas, Gabriela and Schütz, Anna-Lena and Delalle, Ivana and Sananbenesi, Farahnaz and Fischer, Andre},
title = {PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease},
journal = {Acta Neuropathologica},
year = {2024},
doi = {10.1007/s00401-024-02787-x}
}
EUVIMED